PDS Biotech Announces Agreement with University of Georgia to License Novel Proteins for Versamune-based Universal Flu Vaccine

NEXT STORY
Sorrento’s License Partner, Lee’s Pharmaceutical Announces NDA Filing Acceptance by NMPA for Anti-PD-L1 Antibody Socazolimab for Treatment of Recurrent or Metastatic Cervical Cancer
PREV STORY
MEDIA ALERT: Codex DNA Customer to Highlight Advantages of Automated BioXp™ System in Precision Cancer Immunotherapy Applications at 13th Annual PEGS Europe Protein and Antibody Engineering Summit
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Hospital Acquired Disease Testing Market Report 2018: $1.72 Billion Market Trends, Share, Size, Growth, Opportunity and Forecasts 2017-2023

Dublin, Jan. 11, 2019 (GLOBE NEWSWIRE) -- The "Hospital Acquired Disease Testing Market: Global ...

author_avatar
NASDAQ Market News

Nutra Pharma Announces Direct Mail Campaign for Pet Pain-Away™ Private Label Brand

Nutra Pharma is announcing the next phase of marketing their Over-the-Counter (OTC) pain reliever ...

author_avatar
NASDAQ Market News

AB Science granted authorization by ANSM to initiate Phase 2 study evaluating masitinib in combination with isoquercetin for the treatment of COVID-19

author_avatar
NASDAQ Market News